NeuroDex Inc

Biotechnology company · Natick, Massachusetts, United States

NeuroDex Inc is a biotechnology company headquartered in Natick, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $5.3 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $60,000 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

NeuroDex at a glance

Typebiotechnology company
HeadquartersNatick, Massachusetts, United States
Earliest incorporation on record2018
Employees (self-reported, 2024)7
SEC CIK1801963

What does NeuroDex do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $5.3 million in total (2019 to 2024). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute on Aging.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $60,000 sold (2023).

Frequently asked questions about NeuroDex

Where is NeuroDex headquartered?

NeuroDex Inc is headquartered in Natick, Massachusetts, United States.

What does NeuroDex do?

NeuroDex Inc is a biotechnology company.

When was NeuroDex founded?

The earliest incorporation on record for NeuroDex Inc is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences